French pharmacy
Pyralvex Oral and Gingival Solution 10ml quickly relieves canker sores and other oral lesions.
Pyralvex in solution is for the local treatment of inflammatory lesions limited to the oral mucosa and local treatment of mouth ulcers.
The active ingredients are rhubarb (dry hydro-alcoholic sodium extract and purified root equivalent to 0.43 - 0.53% in anthraquinone derivatives) and salicylic acid.
This medicine is to be administered only to adults and children over 6 years of age due to its high alcohol content. It is a 10ml bottle.
The usual dosage of Pyralvex is to apply to the oral lesion with a brush or a cotton swab 2 to 4 applications per day, especially before bedtime. The product should not be swallowed, do not rinse your teeth or your mouth immediately after application.
Comment on the recommendations for use and dosage of Pyralvex Oral and Gingival Solution 10ml with our partner Avis checked after your purchase .
Pyralvex Mouth and Gingival Solution is formulated with:
The active substances are:
Rhubarb (Sodic hydro-alcoholic dry extract and purified from the root assaying 0.43 – 0.53% in anthraquinone derivatives) ......................... .................................................. .................................................. ........... 5.0g
Salicylic acid ................................................ .................................................. ........... 1.0g
For 100ml.
The other ingredients are: 96 percent ethanol, purified water.
What are the side effects and contraindications?
Presentation - Packaging
Oral and Gingival Solution Pyralvex comes in the form of a box containing a 10 ml bottle.
Since ancient times, hydrotherapy has been recognised and appreciated for its health benefits, as well as its soothing and relaxing properties. In this article, we'll look at the different types of hydrotherapy and their benefits for the body. The different forms of hydrotherapy Depending on the water used, its shape and temperature, hydrotherapy can take a number of forms and…
Read the article on the blog
